{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Maintenance Therapy in Advanced Small Cell Lung Cancer

Purpose of Activity

To provide information on the treatment of advanced small cell lung cancer (SCLC) with platinum-based chemotherapy and Lefitolimod.

Learning Objectives/Outcomes

After completing this continuing education activity you will be able to:

  1. Select features of Lefitolimod and methods used to evaluate the efficacy of Lefitolimod in the IMPULSE trial.
  2. Discuss the findings of a study designed to evaluate the use of Lefitolimod as maintenance therapy in advanced SCLC patients who have had standard first-line platinum-based chemotherapy.
Price: $12.95


  • ANCC 1.0 CH
  • DC - BON 1.0 CH
  • FL - BON 1.0 CH
  • GA - BON 1.0 CH

Lippincott Professional Development is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Professional Development is also an approved provider of continuing nursing education by the District of Columbia Board of Nursing, Florida Board of Nursing, and Georgia Board of Nursing, #50-1223.

Test Code: OT1217
Published: Dec 2017
Expires: 12/6/2019
Sources: Oncology Times
Passing Score: 7/10 (70%)
Authors: Richard Simoneaux